Affymax to Present at the BIO CEO & Investor Conference
PALO ALTO, Calif.--(BUSINESS WIRE)--
Affymax, Inc. (Nasdaq: AFFY) today announced that John Orwin, the
company's chief executive officer, will present at the 15th
Annual BIO CEO & Investor Conference on Tuesday, February 12, 2013 at
9:30 a.m. Eastern Time (6:30 a.m. Pacific Time) in New York City.
A live webcast of the presentation will be available on the investors
section of the company's website at http://www.investors.affymax.com/events.cfm.
A replay will also be available for 30 days following the presentation.
About Affymax, Inc.
Affymax, Inc. is a biopharmaceutical company based in Palo Alto,
California. Affymax's mission is to discover, develop and deliver
innovative therapies that improve the lives of patients with kidney
disease and other serious and often life-threatening illnesses.
The company's first marketed product, OMONTYS® (peginesatide)
Injection, was approved by the U.S. Food and Drug Administration (FDA)
in March 2012. For additional information, please visit www.affymax.com.
Alexandra Santos, 650-812-8961
Director, Corporate Communications
Source: Affymax, Inc.
News Provided by Acquire Media
Close window | Back to top